laitimes

Yan'an Bikang Zheng vice chairman and other executives resigned, and the market value shrank by nearly 40 billion yuan in the past year

On July 7, Yan'an Bikang Pharmaceutical Co., Ltd. announced that the board of directors recently received a written resignation report submitted by chairman Gu Xiaojia, vice chairman Li Jingkun, directors He Yudong, Deng Qing, Wang Dong, and vice president Yue Hongbo.

Yan'an Bikang Zheng vice chairman and other executives resigned, and the market value shrank by nearly 40 billion yuan in the past year

According to the announcement, due to personal reasons, Ms. Gu Xiaojia applied to resign as chairman of the board, legal representative, president, member of the strategy committee, member of the audit committee, and member of the remuneration and appraisal committee of the company; Mr. Li Jingkun applied to resign as vice chairman, vice president, member of the strategy committee and member of the nomination committee; Mr. He Yudong applied to resign as a director and vice president of the company; Mr. Deng Qing applied to resign as a director and member of the strategy committee of the company; and Mr. Wang Dong applied to resign as a director of the company; Mr. Yue Hongbo applied to resign as vice president of the company, and the above-mentioned personnel continued to hold other positions in the company after their resignation.

On the same day, Yan'an Bikang also issued an announcement on the change of employee representative supervisors, saying that the Board of Supervisors recently received a written resignation report submitted by Ms. Chen Cong, the employee representative supervisor, and Ms. Chen Cong resigned from the position of employee representative supervisor of the company for personal reasons. After her resignation, Ms. Chen Cong no longer holds any position in the Company.

Behind the resignation of the chairman and vice chairman, the market value has shrunk by nearly 40 billion yuan in the past year

According to the official website, Yan'an Bikang was established in 2002, and in 2015, it was listed on the Shenzhen Stock Exchange on the backdoor 99jiu, and is a modern large-scale pharmaceutical enterprise group integrating APIs, proprietary Chinese medicines, chemicals, biologics, vaccine research and development, health products, health drink production and marketing.

After the listing, yanan bikang scale expanded rapidly, the market value once exceeded 50 billion yuan, its chairman Li Zongsong, Gu Xiaojia and his wife also soared to 14 billion yuan wealth, on the "2020 Hurun global rich list".

The turning point occurred in early 2020, due to the disclosure of new mask production lines and the incomplete information disclosure of drugs related to the epidemic in the new strategic cooperation, the Shenzhen Stock Exchange and the Shaanxi Securities Regulatory Bureau sent regulatory letters and warning letters to Yan'an Bikang on February 18 and March 12 of that year, respectively. Subsequently, on March 36, the Securities Regulatory Commission issued an announcement that due to suspected violations of laws and regulations on information disclosure, it officially filed a case investigation against Shaanxi Bikang, and affected by this news, on March 26, Yan'an Bikang's stock price fell to a halt, closing at only 8.84 yuan / share.

From March 26, 2020 to March 27, 2021, from the peak stock price of 24.80 yuan / share before the investigation was filed to 4.36 yuan / share today. In one year, the market value of Yan'an Bikang Company shrank to nearly 40 billion. As of July 7, the stock price rose to 6.12 yuan / share, still far from the highest stock price.

Newly hired president and many other executives, Yanan Bikang has been saved?

In order to ensure the normal production and operation management and business development of the company, after the qualification nomination and review of the nomination committee of the fifth board of directors, the board of directors agreed to appoint Mr. Shao Xinjun as the president of the company, and Mr. Wang Cheng, Mr. Quan Xinxue, Mr. Yin Dajie, Mr. Kang Xinchang and Mr. Deng Siwei as vice presidents of the company.

According to the announcement, Shao Xinjun, born in July 1975, has a college degree and is a member of the China Democratic Construction Association. He has the qualifications of certified public accountant, certified lawyer, certified tax agent, registered senior consultant and senior economist title, and is one of the first batch of senior members of the Chinese Institute of Certified Public Accountants. From July 2013 to October 2020, he served as a partner of Ruihua Certified Public Accountants and the director of Henan Branch. In July 2021, he joined Yan'an Bikang Company.

Wang Cheng, male, born in December 1972, bachelor degree. He has successively served as the executive deputy general manager and quality authorizer of Bikang Pharmaceutical Xinyi Group Holdings Co., Ltd. He is currently the project leader of Bikang Xinyi.

Quan Xinxue, male, born in April 1975, bachelor degree. He has successively served as the manager of the quality management department of Shaanxi Bikang Pharmaceutical Group Holdings Co., Ltd. and the company's quality authorized person. He is currently the head of pharmaceutical production quality of the company.

Cui Qingwei, female, born in October 1985, MBA student at Xi'an Jiaotong University. He has successively served as the personnel manager of Shandong Buchang Pharmaceutical Co., Ltd., the human resources manager of Shaanxi Bikang Pharmaceutical Group Holding Co., Ltd., and the current human resources director of Shaanxi Bikang Pharmaceutical Group Holding Co., Ltd.

Yin Dajie, male, born in April 1970, bachelor degree, successively served as the production technology supervisor, production technology manager and production leader of Shaanxi Bikang Pharmaceutical Group Holding Co., Ltd. He is currently the vice president of the company and the head of the company's pharmaceutical technology.

For this management change, some netizens commented that "the new president and vice president are experts who understand the management of the management committee and understand technology, especially Vice President Han Wenxiong has served as a Senior Executive of Huawei." Bikang has been saved", the three fires of the new official, how to burn, health times will continue to pay attention. Sun Baoguang sorted